Arvee Laboratories (India) Ltd Financials

Arvee Laboratories (India) Ltd Financial Statement

Arvee Laboratories (India) Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Dec 2024	Sep 2024	Jun 2024
Revenue	9.10	12.68	10.71
Operating Expense	8.56	11.02	9.07
Net Profit	0.15	0.98	0.94
Net Profit Margin	1.65	7.73	8.78
Earning Per Share	0.14	0.89	0.85
EBIDTA	0.53	1.66	1.65
Effective Tax Rate	9.26	19.88	19.51

Particulars	Dec 2024
Revenue	9.10
Operating Expense	8.56
Net Profit	0.15
Net Profit Margin	1.65
Earning Per Share	0.14
EBIDTA	0.53
Effective Tax Rate	9.26

Arvee Laboratories (India) Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	30.35	61.35	40.33
Operating Expenses Annual	27.41	54.07	34.66
Operating Profit Annual	3.58	8.63	6.13
Interest Annual	0.25	0.39	0.36
Depreciation	1.50	2.08	2.32
Net Profit Annual	1.05	4.12	2.57
Tax Annual	0.78	2.05	0.88

Particulars	Mar 2024
Total Revenue Annual	30.35
Operating Expenses Annual	27.41
Operating Profit Annual	3.58
Interest Annual	0.25
Depreciation	1.50
Net Profit Annual	1.05
Tax Annual	0.78

Arvee Laboratories (India) Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.54	1.28	6.61
Cash Flow from Operations	3.66	2.93	0.68
Cash Flow from Investing	-2.16	-1.26	0.06
Cash Flow from Financing	-0.19	-2.42	-6.06
Cash Flow at the End	1.85	0.54	1.28

Particulars	Mar 2024
Cash Flow at the Beginning	0.54
Cash Flow from Operations	3.66
Cash Flow from Investing	-2.16
Cash Flow from Financing	-0.19
Cash Flow at the End	1.85

Arvee Laboratories (India) Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	11.80	14.08	15.22
PBIT Margin (%)	6.85	10.69	9.47
PBT Margin (%)	-20.56	-16.73	-16.12
Net PROFIT Margin (%)	3.46	6.72	6.37
Return On Networth / Equity (%)	3.67	15.85	11.33
Return On Networth /Employed (%)	6.96	23.25	13.31
Return On Assets (%)	3.53	14.57	8.99
Total Debt / Equity (X)	0.04	0.08	0.26
Asset Turnover Ratio (%)	1.02	2.17	1.41

Particulars	Mar 2024
PBDIT Margin (%)	11.80
PBIT Margin (%)	6.85
PBT Margin (%)	-20.56
Net PROFIT Margin (%)	3.46
Return On Networth / Equity (%)	3.67
Return On Networth /Employed (%)	6.96
Return On Assets (%)	3.53
Total Debt / Equity (X)	0.04
Asset Turnover Ratio (%)	1.02

Arvee Laboratories (India) Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	12.67	12.68	13.84
Total Current Assets Annual	16.79	21.57	23.69
Non Current Assets Annual	21.41	17.12	15.00
Total Shareholders Funds Annual	29.11	28.06	23.94
Total Assets Annual	38.20	38.69	38.68

Particulars	Mar 2024
Fixed Assets Annual	12.67
Total Current Assets Annual	16.79
Non Current Assets Annual	21.41
Total Shareholders Funds Annual	29.11
Total Assets Annual	38.20

Arvee Laboratories (India) Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

FAQS on Arvee Laboratories (India) Ltd Financials

As of Feb 22, 2025, Arvee Laboratories (India) Ltd has a market capitalization of 158.03 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Arvee Laboratories (India) Ltd is debt-free with a debt-to-equity ratio of 0.03.

In FY 2024 , Arvee Laboratories (India) Ltd recorded a total revenue of approximately 30.35 Cr marking a significant milestone in the company's financial performance.

Arvee Laboratories (India) Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and -0.1% annually, respectively..

Arvee Laboratories (India) Ltd's current PE ratio is 150.50.

Arvee Laboratories (India) Ltd's ROCE averaged 14.4% from the FY ending March 2022 to 2024, with a median of 14.1%. It peaked at 22.3% in March 2023, reflecting strong capital efficiency over the period..

Arvee Laboratories (India) Ltd's latest EBIT is Rs. 2.08 Cr, surpassing the average EBIT of Rs. 4.15 Cr over the 5 years..